Latest
10:40
10:40
10:25
09:50
09:49
09:48
09:24
08:29
[ AIM Vaccine (06660.HK): Marketing Application Submitted for High-Potency Human Diploid Rabies Vaccine with Optimized Manufacturing Process ] NewTimeSpace News: AIM Vaccine announced on August 24 that the marketing authorization application for its self-developed high-potency human diploid rabies vaccine adopting an optimized production process has been submitted to the National Medical Products Administration.
Tag:
AIM VACCINE06660.HK